Noticias de SNGX_US

Noticias del mercado

Últimas noticias sobre SNGX_US — 88 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SNGX_US ✕ 88 resultados
31/03/2026 SNGX_US — TradingView
Soligenix Inc reports results for the quarter ended December 31 - Earnings Summary
31/03/2026 SNGX_US — Investing.com
Soligenix reports 2025 results, eyes Q2 trial data
30/03/2026 SNGX_US — MarketScreener
Soligenix, Inc. Auditor Raises 'Going Concern' Doubt
26/03/2026 SNGX_US — GuruFocus
Soligenix (SNGX) Gains EU Orphan Drug Designation for Dusquetide in Behcet's Disease
26/03/2026 SNGX_US — PR Newswire
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
26/03/2026 SNGX_US — Stock Titan
EU grants rare-disease status to Soligenix drug for Behçet's
26/03/2026 SNGX_US — Quantisnow
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
26/03/2026 SNGX_US — TradingView
SNGX: Late-stage rare disease therapies and vaccines show strong clinical and commercial promise
26/03/2026 SNGX_US — Investing.com ES ← EN
Soligenix recibe el estatus de medicamento huérfano de la UE para el tratamiento de Behçet
23/03/2026 SNGX_US — Benzinga ES ← EN
Soligenix (NASDAQ: SNGX) fortalece el programa de desarrollo de enfermedades raras a través del diseño de innovación regulatoria del Reino Unido
23/03/2026 SNGX_US — Quantisnow
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
23/03/2026 SNGX_US — Yahoo Finance
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
19/03/2026 SNGX_US — The Globe and Mail
Soligenix (NASDAQ: SNGX) Highlights HyBryte Clinical Data in Peer-Reviewed Journal Publication
19/03/2026 SNGX_US — Aktiellt
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
19/03/2026 SNGX_US — The Manila Times
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
19/03/2026 SNGX_US — Yahoo Finance
Soligenix (SNGX) Highlights HyBryte Clinical Data in Peer-Reviewed Journal Publication
19/03/2026 SNGX_US — PR Newswire
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
19/03/2026 SNGX_US — GlobeNewswire
IBN Announces Latest Episode of The BioMedWire Podcast
19/03/2026 SNGX_US — Yahoo Finance
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
12/03/2026 SNGX_US — Yahoo Finance
SNGX: Important Upcoming Readouts in Phase 3 CTCL Study

Página 4 de 5

keyboard_arrow_up